Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2011/0301183 CHEMICAL SYNTHESIS OF A HIGHLY POTENT EPOTHILONE
A highly active synthetic epothilone compound whose activity exceeds that of either epothilone EpoA or EpoB when assayed as a cytotoxic agent against a cancer...
2011/0301182 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a...
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for improving glycemic control in type 2 diabetes patients...
2011/0301181 halogen-substituted compounds
The invention relates to compounds of the general formula (I), ##STR00001## in which the radicals A.sub.1, A.sub.2, A.sub.3, A.sub.4, Lm, Q, R.sup.1, T and U have...
2011/0301180 Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing...
It has been discovered that inhibiting mitochondrial respiration in platelets reduces platelet activation or platelet aggregation. Certain heterocyclic...
2011/0301179 NAPHTHAMIDES AS ANTICANCER AGENTS
A compound (particularly useful for inhibiting cancer) according to formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein: x is 0...
2011/0301178 PYRAZINYL CARBOXAMIDES AS FUNGICIDES
This present disclosure is related to the field of pyrazine carboxamides and their derivatives and the use of these compounds as fungicides.
2011/0301177 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
The present invention relates to a suspension formulation containing the active substance ...
2011/0301176 IMIDAZOTHIAZOLE DERIVATIVES HAVING PROLINE RING STRUCTURE
There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds...
2011/0301175 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
The invention provides compounds of formula (1) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for...
2011/0301174 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION...
The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present...
2011/0301173 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION...
The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present...
2011/0301172 COMBINATION OF DPP-IV INHIBITOR, PPAR ANTIDIABETIC AND METMORFORMIN
The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, which comprises; 1) a dipeptidylpeptidase-IV...
2011/0301171 Inhibitors of JNK
Compounds of formula I ##STR00001## or pharmaceutically acceptable salts thereof, wherein R.sup.5 is a group of formula (a) or (b): ##STR00002## and wherein m,...
2011/0301170 Inhibitors of JNK
Compounds of formula I ##STR00001## or pharmaceutically acceptable salts thereof, wherein: wherein m, n, p, q, X Y, Z, A, R.sup.1, R.sup.2, R.sup.3, R.sup.4,...
2011/0301169 Therapies for Treating Cancer Using Combinations of COX-2 Inhibitors and Antimetabolites
A method for treating a subject having cancer, comprising administering to the subject, a therapeutically effective amount of a combination comprising a...
2011/0301168 CYCLOALKANE[B]AZAINDOLE ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
Described herein are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein,...
2011/0301167 PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
The present invention is directed to pyrazolo[4,3-c]cinnolin-3-one compounds of formula (I) which are M1 receptor positive allosteric modulators and that are...
2011/0301166 METHOD FOR THE PREVENTION OF THROMBOEMBOLIC DISORDERS
A method for the prevention of thrombotic, embolic and/or hemorrhagic disorders, such as cerebral infarction (stroke) or myocardial infarction, by administering...
2011/0301165 METHOD FOR TREATING AND PREVENTING ARTHRITIS
Compounds represented by the formula 1: ##STR00001## wherein each R individually is H, an aliphatic acyl group or an aromatic acyl group; A is selected from the...
2011/0301164 METHOD OF ADMINISTERING OPHTHALMIC FLUIDS
A method is provided of treating an eye with ophthalmologically active compounds, particularly with intra-ocular pressure lowering (IOP) compounds, where a dose...
2011/0301163 QUINOLINE COMPOUNDS AS INHIBITORS OF ANGIOGENESIS, HUMAN METHIONINE AMINOPEPTIDASE, AND SIRT1, AND METHODS OF...
Described herein are methods of inhibiting methionine aminopeptidase or SirT1, inhibiting angiogenesis, and treating disorders (or symptoms thereof) associated...
2011/0301162 AURORA KINASE MODULATORS AND METHODS OF USE
The present invention relates to chemical compounds having a general formula I ##STR00001## wherein A.sup.1-6, L.sup.1, R.sup.1, R.sup.4-6 and n are defined...
2011/0301161 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION
The present invention relates to compounds of formula (I): ##STR00001## and pharmaceutically acceptable salt thereof, wherein R.sup.1-R.sup.7 are as defined...
2011/0301160 Inhibitors of P38 and Methods of Using the Same
In general, the present invention relates to compounds capable of inhibiting p38 in vivo or in vitro, and methods for treating conditions associated with p38...
2011/0301159 KINASE INHIBITOR COMPOUNDS
The disclosure relates to novel compounds that are capable of modulating Jak2 kinase activities, compounds that have therapeutic use in treating or preventing a...
2011/0301158 ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct...
2011/0301157 BICYCLIC AMIDES AS KINASE INHIBITORS
The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a...
2011/0301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use...
Vanilloid receptor ligand compounds corresponding to formula I: ##STR00001## pharmaceutical compositions containing such compounds, a process for producing such...
2011/0301155 INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE
The present invention aims to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes,...
2011/0301154 SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS,...
The present invention involves new and original sigma receptors Ligands: (Mono-or dialkylaminoalkyl)-.gamma.-butyro-lactones, their analogues ...
2011/0301153 METHODS OF TREATING CANCER
The invention concerns methods of treating cancer comprising contacting said tumors with a chemical inhibitor of glutaminolysis. These inhibitors include...
2011/0301152 NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine...
2011/0301151 DIMERIC IAP INHIBITORS
Molecular mimics of Smac are capable of modulating apoptosis through their interaction with cellular IAPs (inhibitor of apoptosis proteins). The mimetics are...
2011/0301150 SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING...
Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the...
2011/0301149 COMPOSITIONS AND METHODS FOR TREATING ALCOHOL USE DISORDERS, PAIN AND OTHER DISEASES
The present invention provides compounds which antagonize epsilon protein kinase C (PKC.epsilon.). These compounds have a structural formula (Ia), (Ic) or (II)....
2011/0301148 DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF
The invention relates to compounds corresponding to formula (I), in the form of the base or of an acid-addition salt: ##STR00001## in which n is equal to 0, 1, 2,...
2011/0301147 Modified release preparations containing oxcarbazepine and derivatives thereof
Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise...
2011/0301146 GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES
GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula...
2011/0301145 PYRIDAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF
Compounds of Formula I that inhibit Btk are described herein. Pharmaceutical compositions comprising at least one compound of Formula I, together with at least...
2011/0301144 Kinase Antagonists
The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and...
2011/0301143 HETEROCYCLIC DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
Heterocyclic compounds of structural formula (I), or a pharmaceutically acceptable salt thereof, wherein W is a R.sup.1-- substituted heteroaryl, R.sup.1 is an...
2011/0301142 ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include...
2011/0301141 AMINOPYRIMIDINE DERIVATIVES AS LRRK2 INHIBITORS
Compounds of the formula I: ##STR00001## or pharmaceutically acceptable salts thereof, wherein m, n. X, R.sup.1, R.sup.2, R.sup.3, R.sup.5, R.sup.6 and R.sup.7...
2011/0301140 Pyridine Carboxamide orexin Receptor Antagonists
The present invention is directed to pyridyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or...
2011/0301139 PHARMACEUTICAL COMPOSITIONS OF CEFIXIME
A pharmaceutical suspension dosage form comprising greater than 80 mg/ml and not more than 150 mg/ml of Cefixime and pharmaceutically acceptable excipients.
2011/0301138 PROCESS TO MAKE FUSIDIC ACID CREAM
The invention discloses a process to make dermaceutical cream containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material,...
2011/0301137 DERMACEUTICAL GEL MADE USING SODIUM FUSIDATE AND A PROCESS TO MAKE IT
The invention discloses a process to make dermaceutical gel containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material,...
2011/0301136 Nitrate Esters Of Corticoid Compounds Useful As Diuretics
The present invention relates to the diuretic effects of nitrate esters of corticoid compounds. A patient in heart failure may be treated by administering a...
2011/0301135 STABILIZATION OF GLUCOCORTICOID ESTERS WITH ACIDS
The invention relates to nonaqueous pharmaceutical preparations comprising a glucocorticoid ester and an acid, and to the stabilization of glucocorticoid esters...
2011/0301134 ALKYNE ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.